SP
TMO icon

Stablepoint Partners’s Thermo Fisher Scientific TMO Stock Holding History

Stablepoint Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Sell
3,603
-177
-5% -$85K 0.25% 113
2026
Q1 		$1.86M Sell
3,780
-446
-11% -$242K 0.28% 102
2025
Q4 		$2.45M Sell
4,226
-15
-0.4% -$8.48K 0.38% 84
2025
Q3 		$2.06M Buy
4,241
+337
+9% +$157K 0.33% 94
2025
Q2 		$1.58M Buy
3,904
+8
+0.2% +$3.35K 0.27% 107
2025
Q1 		$1.94M Buy
3,896
+98
+3% +$53.1K 0.35% 86
2024
Q4 		$1.98M Sell
3,798
-135
-3% -$74.2K 0.36% 91
2024
Q3 		$2.43M Buy
3,933
+32
+0.8% +$18.9K 0.44% 71
2024
Q2 		$2.36M Buy
3,901
+179
+5% +$103K 0.46% 67
2024
Q1 		$2.16M Buy
3,722
+700
+23% +$393K 0.44% 72
2023
Q4 		$1.6M Buy
+3,022
New +$1.46M 0.41% 72

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Stablepoint Partners's TMO Position: Q2 2026 in Review

Stablepoint Partners reduced its Thermo Fisher Scientific (TMO) stake by 4.7% in Q2 2026, selling an estimated $85K and leaving 3,603 shares worth $1.81M. The position accounts for 0.25% of the portfolio, ranked #113.

Stablepoint Partners first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.45M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Stablepoint Partners held 3,603 shares of Thermo Fisher Scientific worth $1.81M as of Q2 2026.
  • Stablepoint Partners sold 177 Thermo Fisher Scientific shares in Q2 2026, an estimated $85K.
  • Thermo Fisher Scientific made up 0.25% of Stablepoint Partners's portfolio in Q2 2026, its #113 holding.
  • Stablepoint Partners first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Stablepoint Partners's Thermo Fisher Scientific position peaked at $2.45M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.